About 1 result found for searched term "Pirtobrutinib (LOXO-305)" (0.165 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M10604 | Pirtobrutinib (LOXO-305) | BTK |
| LY 3527727; RXC-005 | ||
| Pirtobrutinib (LOXO-305; LY 3527727; RXC-005) is a first-in-class, highly selective, non-covalent, next-generation BTK inhibitor with an IC50 of 5.69 nM in WT BTK HEK cells.Pirtobrutinib's selectivity for BTK more than 300 times more selective than other 370 kinases. Pirtobrutinib can be used in studies related to chronic lymphocytic leukemia (CLL). | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.
